glp 1 agonists mechanism of action GLP-1 Receptor as Treatments for Type 2 Diabetes GLP1 Receptor Agonists—Effects beyond Obesity
Description
That puts a lot of pressure on the generics-and we have spoken to the companies at length earlier in the year before the launch of Mounjaro and Wegovy-that were earlier expected to launch at 7,000-8,000 for a month's dose," said leading diabetologist Rajiv Kovil
doi:10.1001/jamanetworkopen.2025.26321,
Misleading promotions may trigger enforcement actions, reputational harm, and litigation
Braslov et al
